12:00 AM
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Illumina, Teva, Clalit Health Services sales and marketing update

Illumina's Verinata Health Inc. subsidiary granted Teva exclusive, five-year commercialization rights to Verinata's verifi prenatal test in Israel. Clalit's MOR Institute for Medical Data Ltd. subsidiary, through an undisclosed relationship with...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >